Health Canada5 Oct 2026
PDP-DIPHENHYDRAMINE 25 MG CAPSULE: Out-of-specification (Impurity)
Health Canada published a recall notice for PDP-DIPHENHYDRAMINE 25 MG CAPSULE: Out-of-specification (Impurity) on 5 Oct 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 5 Oct 2026
- Recall type
- Health product recall
- Companies
- Pendopharm Division of Pharmascience Inc.6111 avenue Royalmount suite 100, · Montréal, QC H4P 2T4
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The impurity, N-Nitroso-N-Desmethyl Diphenhydramine, is out of specification in the affected lots. What you should do What to do: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Pendopharm PDP-DIPHENHYDRAMINE DIN 00757683 Capsule 25 MG 642913 643904 648034 651074 653544 656693 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.